Marhadour, S. | IICIMED

Marhadour, S.

Publications

P155

Anticancer Res. 2016, 36, 1621-1630.

Discovery of (imidazo[1,2-a]pyrazin-6-yl)ureas as antiproliferative agents targeting P53 in non-small cell lung cancer cell lines.

Bazin, M.-A. | Rousseau, B. | Marhadour, S. | Tomasoni, C. | Evenou, P. | Piessard, S. | Vaisberg, A. J. | Ruchaud, S. | Bach, S. | Roussakis, C. | Marchand, P.

P136

Eur. J. Med. Chem. 2015, 103, 381-395.

Synthesis, antileishmanial activity and cytotoxicity of 2,3-diaryl- and 2,3,8-trisubstituted imidazo[1,2-a]pyrazines.

Marchand, P. | Bazin, M.-A. | Pagniez, F. | Rivière, G. | Bodero, L. | Marhadour, S. | Nourrisson, M.-R. | Picot, C. | Ruchaud, S. | Bach, S. | Baratte, B. | Sauvain, M. | Castillo Pareja, D. | Vaisberg, A. J. | Le Pape, P.

doi: 10.1016/j.ejmech.2015.09.002

P117

Tetrahedron Lett., 2013, 54, 5378-5382. 

Exploration of versatile reactions on 2-chloro-3-nitroimidazo[1,2-a]pyridine: expanding structural diversity of C2- and C3-functionalized imidazo[1,2-a]pyridines.

Bazin, M.-A. | Marhadour, S. | Tonnerre, A. | Marchand, P.

P108

 Eur. J. Med. Chem., 2012, 58, 543-556. 

Synthesis and biological evaluation of 2,3-diarylimidazo[1,2-a]pyridines as antileishmanial agents.

Marhadour, S. | Marchand, P. | Pagniez, F. | Bazin, M.-A. | Picot, C. | Lozach, O. | Ruchaud, S. | Antoine, M. | Meijer, L. | Rachidi, N. | Le Pape, P.

P99

Tetrahedron Lett., 2012, 53, 297-300.

An efficient access to 2,3-diarylimidazo[1,2-a]pyridines via imidazo[1,2-a]pyridine-2-yltriflate through a Suzuki cross-coupling reaction-direct arylation sequence.

Marhadour, S. | Bazin, M.-A. | Marchand, P.

Autres publications scientifiques

Brevets

Thèse

T28.

Synthèse et évaluation biologique d'imidazo[1,2-α]pyridines et imidazo[1,2-α]pyrazines substituées.

Marhadour, S.

Nantes, date de soutenance : 25 octobre 2012.